Holen Sie sich die Stockscreener-App
343.57
1.31%
4.5398
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$339.03
Offen:
$337.03
24-Stunden-Volumen:
940.22K
Relative Volume:
0.35
Marktkapitalisierung:
$131.73B
Einnahmen:
$25.27B
Nettoeinkommen (Verlust:
$3.34B
KGV:
39.80
EPS:
8.6334
Netto-Cashflow:
$4.57B
1W Leistung:
+0.66%
1M Leistung:
+4.15%
6M Leistung:
-4.87%
1J Leistung:
-9.04%
1-Tages-Spanne:
$335.00
$343.79
1-Wochen-Bereich:
$330.16
$343.87
52-Wochen-Spanne:
$281.00
$396.86
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
343.63 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
108.73 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
89.00 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.70 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.51 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Leerink Partners | Outperform |
| 2026-02-20 | Eingeleitet | William Blair | Outperform |
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Stryker (SYK) Launches Mako RPS To Bring Robotic Knee Surgery To More Surgeons - Yahoo Finance
UBS reiterates Stryker stock Buy rating with $400 price target - Investing.com
Ultrasonic Aspirator Market Size Projected to Reach USD 376.32 Million by 2035 | SNS Insider - GlobeNewswire Inc.
UBS reiterates Stryker stock Buy rating with $400 price target By Investing.com - Investing.com Canada
Stryker Corp (SYK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Lyle Stein's Top Picks: ExxonMobil, iShares MSCI South Korea ETF & Stryker - BNN Bloomberg
Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders - Yahoo Finance
Stryker Corp (SYK) Cash Flow - TradingKey
Stryker Corp (SYK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stryker stock trades near highs as orthopedic demand supports revenue growth - Ad-hoc-news.de
Stryker Corp (SYK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SYK|Stryker Corp|Price:336.750|Chg%:+6.500 - TradingKey
SYK|Stryker Corp|Price:330.250|Chg%:+11.440 - TradingKey
Stryker Corp Stock (SYK) Moved Up by 3.15% on Jul 24: Facts Behind the Movement - TradingKey
Stryker Gains as Recovery Optimism Builds Ahead of Q2 Results - Moomoo
Stryker Corp Stock (SYK) Closed Up by 3.21% on Jul 23: Drivers Behind the Movement - TradingKey
Stryker Corp (SYK) Institutional Confidence - TradingKey
Stryker stock holds gains as medical device growth supports valuation - AD HOC NEWS
Stryker Corp (SYK) Shares Surge 3.1% -- What GF Score of 92 Tells Investors - GuruFocus
The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants - Yahoo Finance
Stryker (SYK) Offers Attractive Valuations Amid Market Shifts - GuruFocus
Stryker stock trades steadily as medical device growth supports valuation - AD HOC NEWS
Boston Scientific Settles With Stryker In Spine Device IP Fight - Law360
Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker - Yahoo Finance
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific, Stryker Settle Surgical Device Patent Dispute - Bloomberg Law News
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Stryker stock trades steadily as recent earnings and growth investments shape outlook - Ad-hoc-news.de
Stryker stock builds on earnings momentum after 16 July 2026 update - Ad-hoc-news.de
Stryker stock trades on its latest reported growth - ad-hoc-news.de
Mako Handheld Robotic Knee System Launch Might Change The Case For Investing In Stryker (SYK) - Yahoo Finance
Is Stryker Corp (SYK) a Bargain After 3.4% Drop? GF Value Says U - GuruFocus
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Stryker Corp Stock (SYK) Moved Down by 3.42% on Jul 17: A Full Analysis - TradingKey
Stryker stock trades near highs as robotics and trauma growth support valuation - ad-hoc-news.de
Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio - The Globe and Mail
Stryker Corp (XTER:SYK) Stock Price, Trades & News - GuruFocus
Stryker (SYK) Launches Mako RPS Handheld Robot for Knee Replacem - GuruFocus
Stryker Shares Rise After Commercial Launch of Mako Robotic Power System - Moomoo
Stryker (SYK) Introduces Mako RPS for Total Knee Replacements - GuruFocus
Stryker launches Mako RPS handheld robotic knee system in U.S. - Investing.com
Stryker expands Mako robotics portfolio with full market release of Mako RPS - Finviz
Stryker expands Mako robotics portfolio with full market release of Mako RPS – Company Announcement - Financial Times
Stryker's quarterly earnings preview: What you need to know - MSN
Stryker Corp (SYK) Stock Down 6.2% -- Now Undervalued? GF Score: 92/100 - GuruFocus
Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating - Moomoo
Stryker Corp Stock (SYK) Moved Down by 5.49% on Jul 14: A Full Analysis - TradingKey
Fund Update: 43,404 STRYKER (SYK) shares added to Douglas Lane & Associates, LLC portfolio - Quiver Quantitative
Stryker Slides As Investors Reassess Cyberattack Recovery Ahead Of Q2 Results - Quiver Quantitative
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Stryker Corp-Aktie (SYK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
May 26 '26 |
Sale |
312.23 |
310,000 |
96,792,669 |
1,924,880 |
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):